ARK Investment Management - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 76 filers reported holding UROGEN PHARMA LTD in Q1 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.5%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$3,015,961
+44.3%
215,272
+6.6%
0.02%
+64.3%
Q2 2023$2,089,851
-16.5%
201,918
-25.4%
0.01%
-17.6%
Q1 2023$2,501,693
+43.2%
270,746
+37.5%
0.02%
+13.3%
Q4 2022$1,746,840
-25.5%
196,938
-30.1%
0.02%
-6.2%
Q3 2022$2,344,000
+45.9%
281,701
-6.8%
0.02%
+60.0%
Q2 2022$1,607,000
-44.7%
302,124
-9.4%
0.01%
-16.7%
Q1 2022$2,905,000
+63.8%
333,472
+78.8%
0.01%
+140.0%
Q4 2021$1,774,000
-56.8%
186,493
-23.6%
0.01%
-50.0%
Q3 2021$4,107,000
-15.0%
244,165
-22.8%
0.01%
+11.1%
Q2 2021$4,829,000
-15.1%
316,248
+8.4%
0.01%
-18.2%
Q1 2021$5,686,000
+327.8%
291,870
+295.7%
0.01%
+175.0%
Q4 2020$1,329,000
+101.4%
73,769
+115.6%
0.00%0.0%
Q3 2020$660,000
-46.5%
34,212
-27.5%
0.00%
-69.2%
Q2 2020$1,233,000
+311.0%
47,208
+180.6%
0.01%
+85.7%
Q1 2020$300,000
-43.9%
16,821
+5.0%
0.01%
-46.2%
Q4 2019$535,000
+57.8%
16,025
+12.6%
0.01%
+85.7%
Q3 2019$339,000
-30.2%
14,235
+5.2%
0.01%
-41.7%
Q2 2019$486,000
+45.9%
13,529
+50.2%
0.01%
+20.0%
Q1 2019$333,000
-31.5%
9,007
-20.3%
0.01%
-50.0%
Q4 2018$486,000
-8.6%
11,298
+0.4%
0.02%
+25.0%
Q3 2018$532,000
+13.2%
11,258
+19.3%
0.02%
-5.9%
Q2 2018$470,000
-30.0%
9,438
-30.1%
0.02%
-48.5%
Q1 2018$671,000
+94.5%
13,502
+45.4%
0.03%
+22.2%
Q4 2017$345,0009,2840.03%
Other shareholders
UROGEN PHARMA LTD shareholders Q1 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,620,545$36,713,8356.69%
Wildcat Capital Management, LLC 495,606$6,943,4402.79%
SILVERARC CAPITAL MANAGEMENT, LLC 508,883$7,129,4512.16%
Opaleye Management Inc. 320,000$4,483,2001.46%
AlphaCentric Advisors LLC 165,000$2,311,6501.31%
Soleus Capital Management, L.P. 372,000$5,211,7200.48%
EAM Investors, LLC 170,523$2,389,0270.46%
RA Capital Management 1,483,697$20,786,5950.41%
Parkman Healthcare Partners LLC 145,311$2,035,8070.37%
MENORA MIVTACHIM HOLDINGS LTD. 2,303,031$32,265,4640.29%
View complete list of UROGEN PHARMA LTD shareholders